The Big Business of Swine Flu

Americans are still debating whether to roll up their sleeves for a swine flu shot, but companies have already figured it out: vaccines are good for business.

Drug companies have sold $1.5 billion worth of swine flu shots, in addition to the $1 billion for seasonal flu they booked earlier this year. These inoculations are part of a much wider and rapidly growing $20 billion global vaccine market. Full Story »

Posted by Michael Bugeja

See All Reviews »

Review

Fabrice Florin
3.8
by Fabrice Florin - Oct. 14, 2009

Thorough report about swine flu vaccines and who benefits from them: big pharma companies like Sanofi-Pasteur, Glaxo Smith Kline and Novartis. This article provides detailed factual evidence from many credible sources, citing physicians, researchers and industry representatives to give a contextual overview of this newsworthy topic.

See All Reviews »

Fabrice's Rating

Overall
3.8

Good
from 11 answers
Quality
3.8
Facts
4.0
Fairness
4.0
Sourcing
4.0
Style
3.0
Context
4.0
Depth
4.0
Enterprise
3.0
Relevance
4.0
Popularity
3.5
Recommendation
3.0
Credibility
4.0
More How our ratings work »